Webinar: Corning® HepatoCells: A Novel Cell-Based Model for In Vitro ADME/Tox Studies

We use cookies to ensure the best experience on our website.
View Cookie Policy
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

Esta página possui melhor visualização com última versão do Google Chrome e do Mozilla Firefox.

Close[x]
Events
CLS
Webinar: Corning® HepatoCells: A Novel Cell-Based Model for In Vitro ADME/Tox Studies
Corning® HepatoCells Webinar
Corning® HepatoCells Webinar
September 30, 2015 | 12:00 PM EST - 01:00 PM EST

Abstract:

Primary human hepatocytes (PHHs) and other hepatic cell models possess several limitations. For instance, PHH’s large lot-to-lot variation requires qualification tests with each lot, resulting in high costs and increased lead time. Furthermore, other non-primary hepatic cells can have insufficient fold induction in some lots and conditions.

This presentation will introduce Corning® HepatoCells for ADME/Tox studies. Derived from primary human hepatocytes, Corning HepatoCells are a renewable, hepatocyte-like cell line that retains most of the physiological properties of their parental hepatocytes such as mature hepatocyte-like morphology and induction response to prototypical inducers of CYP3A4, 1A2, and 2B6. Characterization of Corning HepatoCells for ADME/Tox studies will be presented, along with data demonstrating how the model system can be used for prediction of clinical CYP induction.

Presenter Info:

Dr. Rongjun Zuo is currently a Senior Development Scientist in the Corning Life Sciences ADME group. She has more than 7 years experience developing cell-based assays for in vitro ADME study including metabolic stability, drug-drug interactions, and transporter assays, with a focus on hepatocyte product applications. Dr. Zuo obtained her Ph.D. degree from University of Connecticut working on the molecular biology of bacteria biofilm. She obtained her post-doc training at the Center for Engineering in Medicine affiliated with Massachusetts General Hospital, the Harvard Medical School, working on liver tissue engineering.

 

Register Now